Verdaguer J - Search Results

1

Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.

Verdaguer J, Amrani A, Anderson B, Schmidt D, Santamaria P. Verdaguer J, et al. J Immunol. 1999 Apr 15;162(8):4614-26. J Immunol. 1999. PMID: 10202001

2

A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens.

Almenara-Fuentes L, Rodriguez-Fernandez S, Rosell-Mases E, Kachler K, You A, Salvado M, Andreev D, Steffen U, Bang H, Bozec A, Schett G, Le Panse R, Verdaguer J, Dalmases M, Rodriguez-Vidal S, Barneda-Zahonero B, Vives-Pi M. Almenara-Fuentes L, et al. Among authors: verdaguer j. Nanomedicine. 2023 Feb;48:102635. doi: 10.1016/j.nano.2022.102635. Epub 2022 Dec 5. Nanomedicine. 2023. PMID: 36481472 Free article.

3

Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.

Verdaguer J, Yoon JW, Anderson B, Averill N, Utsugi T, Park BJ, Santamaria P. Verdaguer J, et al. J Immunol. 1996 Nov 15;157(10):4726-35. J Immunol. 1996. PMID: 8906855

4

A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.

Schmidt D, Verdaguer J, Averill N, Santamaria P. Schmidt D, et al. Among authors: verdaguer j. J Exp Med. 1997 Oct 6;186(7):1059-75. doi: 10.1084/jem.186.7.1059. J Exp Med. 1997. PMID: 9314555 Free PMC article.

5

Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice.

Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P. Verdaguer J, et al. J Exp Med. 1997 Nov 17;186(10):1663-76. doi: 10.1084/jem.186.10.1663. J Exp Med. 1997. PMID: 9362527 Free PMC article.

6

Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.

Schmidt D, Amrani A, Verdaguer J, Bou S, Santamaria P. Schmidt D, et al. Among authors: verdaguer j. J Immunol. 1999 Apr 15;162(8):4627-36. J Immunol. 1999. PMID: 10202002

7

Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.

Amrani A, Verdaguer J, Anderson B, Utsugi T, Bou S, Santamaria P. Amrani A, et al. Among authors: verdaguer j. J Clin Invest. 1999 Apr;103(8):1201-9. doi: 10.1172/JCI6266. J Clin Invest. 1999. PMID: 10207172 Free PMC article.

8

Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.

Anderson B, Park BJ, Verdaguer J, Amrani A, Santamaria P. Anderson B, et al. Among authors: verdaguer j. Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9311-6. doi: 10.1073/pnas.96.16.9311. Proc Natl Acad Sci U S A. 1999. PMID: 10430939 Free PMC article.

9

IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.

Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P. Amrani A, et al. Among authors: verdaguer j. J Clin Invest. 2000 Feb;105(4):459-68. doi: 10.1172/JCI8185. J Clin Invest. 2000. PMID: 10683375 Free PMC article.

10

Progression of autoimmune diabetes driven by avidity maturation of a T-cell population.

Amrani A, Verdaguer J, Serra P, Tafuro S, Tan R, Santamaria P. Amrani A, et al. Among authors: verdaguer j. Nature. 2000 Aug 17;406(6797):739-42. doi: 10.1038/35021081. Nature. 2000. PMID: 10963600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters